● This GMP certification for the company’s production facilities has added to its portfolio of international approvals from 25 regulators● The recognition demonstrates Venus Remedies’ persistence in adhering to stringent manufacturing standards and providing greater access to life-saving drugs in the African continentBengaluru, January 24, 2024: Venus Remedies, a globally recognised pharmaceutical company, has been awarded the Good Manufacturing Practices (GMP) certification for its facilities from the Ministry of Health, Libya. Mr. Saransh Chaudhary, CEO of Venus Medicine Research Centre, said, ” The GMP certification from Libya adds to Venus Remedies’ portfolio of international approvals from 25 regulators, complementing our existing certifications in Africa from Morocco, South Africa, Tanzania, Kenya, Uganda, Sudan and other African countries. Its strategic location in Africa and evolving pharmaceutical landscape provide Venus Remedies with an opportunity to contribute positively to the region’s healthcare sector. This certification is a step towards enhancing the company’s presence in Africa, aligning with its broader vision of improving access to life-saving medicines across the continent. Lauding the achievement, Mr. Akshansh Chaudhary, Executive Director of Venus Remedies, said, “We are thankful to our customers, partners and stakeholders for their constant support.
